Improve the care of cancer patients and reduce healthcare costs through advances in label-free chemical imaging and fiber-laser technology.
INVENIO IMAGING, Inc. was founded in 2012 based on research from the group of Prof. Sunney Xie of the Department of Chemistry and Chemical Biology at Harvard University. With funding from the National Science Foundation (NSF) Small Business Innovation Research (SBIR) Program, the National Institutes of Health (NIH) Bioengineering Research Partnership Program and the University of Michigan Translational Research and Commercialization (MTRAC) initiative we delivered the first fully integrated Stimulated Raman Scattering (SRS) research microscope to the group of Dr. Daniel Orringer at the University of Michigan (Nature Biomedical Engineering 1, 27 (2017)). The system has been validated at Michigan Medicine on samples from over 400 patients. With funding from the NIH SBIR program we are proud to announce the first clinical Stimulated Raman Histology (SRH) imaging system.
Jay Trautman, PhD
President & CEO
Experienced executive in the pharmaceutical and life science industry. Formerly member of Technical Staff at AT&T Bell Labs and winner of R&D 100 award.
Chris Freudiger, PhD
Co-Inventor of SRS microscopy and fiber laser expert. Formerly student and postdoc in the Xie Group (Harvard).
Jonathan Ross, MBA
Experienced in entrepreneurial business management, investment underwriting, venture capital, corporate finance and business development at Convexus Advisors, Babcock& Brown, GATX Capital, Cargill Financial Services and Piper Jaffray.
Scientific & Medical Advisors
Daniel Orringer, MD
Chair of the Medical Advisory Board
Assistant Professor of Neurological Surgery at University of Michigan. His research is focused on improving the delineation of brain turmors during surgery using SRH.
Sunney Xie, PhD
Chair of the Scientific Advisory Board
Mallinckrodt Professor of Chemistry and Chemical Biology (Harvard). Pioneer of SRS microscopy and member of National Academy of Sciences.
INVENIO IMAGING Inc. has an exclusive license to portions of the SRS patent portfolio assigned to Harvard University.